GlaxoSmithKline, Vir Biotechnology Seek Emergency FDA Authorization For COVID-19 Drug
GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc. (NASDAQ: VIR) have submitted an application to the Food and Drug Administration requesting emergency use authorization for VIR-7831, an investigational dual-ac